{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:13:11Z","timestamp":1793401991292,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>The risk of intrahepatic cholestasis of pregnancy [ICP] is increased in thiopurine-exposed pregnancies. Thiopurine \u2018shunting\u2019, with a 6-methylmercaptopurine [MMP] to 6-thioguanine [TGN] ratio of\u2005&amp;gt;11, progresses over pregnancy, and may promote ICP development. We aimed to explore the association between thiopurine exposure and ICP, including the hypothesised impact of thiopurine shunting, and identify risk minimisation strategies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This prospective multicentre cohort study compared thiopurine and biologic monotherapy-exposed pregnant participants. Disease activity and obstetric outcome data, thiopurine metabolites, bile acids, and transaminases were obtained before conception, in each trimester, at delivery, and postpartum. Thiopurine dose management was at the discretion of the treating physician.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Included were 131 thiopurine and 147 biologic monotherapy-exposed pregnancies. MMP\/TGN ratio increased from preconception to third trimester [p\u2005&amp;lt;0.01], with approximately 25% of participants shunting in pregnancy. Second trimester split dosing led to a decrease in the median MMP\/TGN ratio from 18 (interquartile range [IQR] 6-57) to 3 [IQR 2-3.5] at delivery [p\u2005=\u20050.04]. The risk of ICP was increased in thiopurine-exposed pregnancies (6.7% [7\/105] vs 0% [0\/112], p\u2005&amp;lt;0.001), with all ICP cases occurring in the setting of antenatal thiopurine shunting. Thiopurine dose increases (risk ratio [RR] 8.10, 95% confidence interval [CI] 1.88-34.85, p\u2005=\u20050.005) and shunting in third trimester [6.20, 1.21-30.73, p\u2005=\u20050.028] and at delivery [14.18, 1.62-123.9, p\u2005=\u20050.016] were associated with an increased risk of ICP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Thiopurine exposure is associated with an increased risk of ICP, particularly following dose increases antenatally and with shunting in late pregnancy. The latter may be effectively managed with split dosing, although further studies are warranted.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjae023","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T05:05:53Z","timestamp":1708146353000},"page":"1081-1090","source":"Crossref","is-referenced-by-count":25,"title":["Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing"],"prefix":"10.1093","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4331-9295","authenticated-orcid":false,"given":"Ralley","family":"Prentice","sequence":"first","affiliation":[{"name":"Monash Health, Gastroenterology Department , Melbourne, VIC , Australia"},{"name":"St Vincent\u2019s Hospital Melbourne, Gastroenterology Department , Melbourne, VIC , Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3911-4780","authenticated-orcid":false,"given":"Emma","family":"Flanagan","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Hospital Melbourne, Gastroenterology Department , Melbourne, VIC , Australia"},{"name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Wright","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Hospital Melbourne, Gastroenterology Department , Melbourne, VIC , Australia"},{"name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lani","family":"Prideaux","sequence":"additional","affiliation":[{"name":"Monash Health, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Connell","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Hospital Melbourne, Gastroenterology Department , Melbourne, VIC , Australia"},{"name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Sparrow","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, VIC , Australia"},{"name":"Alfred Health, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"De Cruz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, VIC , Australia"},{"name":"Austin Health, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lust","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Hospital Melbourne, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winita","family":"Hardikar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne , Melbourne, VIC , Australia"},{"name":"Royal Children\u2019s Hospital, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimma","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Monash Health, Gastroenterology Department , Melbourne, VIC , Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vogrin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-6291","authenticated-orcid":false,"given":"Kirsten","family":"Palmer","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, VIC , Australia"},{"name":"Monash Health, Maternofoetal Medicine Department , Melbourne, VIC , Australia"},{"name":"Monash Health, Obstetrics and Gynaecology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Ross","sequence":"additional","affiliation":[{"name":"St Vincent\u2019s Hospital Melbourne, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Burns","sequence":"additional","affiliation":[{"name":"Monash Health, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Greeve","sequence":"additional","affiliation":[{"name":"Monash Health, Gastroenterology Department , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Bell","sequence":"additional","affiliation":[{"name":"Monash Health, Gastroenterology Department , Melbourne, VIC , Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Monash University , Melbourne, VIC , Australia"},{"name":"Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne , Melbourne, VIC , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"2024080621445598000_CIT0001","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/138920009790711887","article-title":"On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance","volume":"10","author":"Van Asseldonk","year":"2009","journal-title":"Curr Drug Metab"},{"key":"2024080621445598000_CIT0002","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gutjnl-2012-303615","article-title":"Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease","volume":"63","author":"Jharap","year":"2014","journal-title":"Gut"},{"key":"2024080621445598000_CIT0003","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/apt.16448","article-title":"Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and\/or anti-TNF: a French nationwide study 2010-2018","volume":"54","author":"Meyer","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0004","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1471-0528.2002.01368.x","article-title":"Obstetric cholestasis, outcome with active management: a series of 70 cases","volume":"109","author":"Kenyon","year":"2002","journal-title":"BJOG"},{"key":"2024080621445598000_CIT0005","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.clinre.2019.04.004","article-title":"Thiopurine hepatotoxicity can mimic intrahepatic cholestasis of pregnancy","volume":"44","author":"Nasser","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2024080621445598000_CIT0006","doi-asserted-by":"crossref","first-page":"102083","DOI":"10.1016\/j.jogoh.2021.102083","article-title":"Intrahepatic cholestasis of pregnancy associated with azathioprine: A case series","volume":"50","author":"C\u00e9ruti","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2024080621445598000_CIT0007","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/gutjnl-2019-319129","article-title":"Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life","volume":"70","author":"Kanis","year":"2021","journal-title":"Gut"},{"key":"2024080621445598000_CIT0008","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/apt.16294","article-title":"Maternal thiopurine metabolism during pregnancy in inflammatory bowel disease and clearance of thiopurine metabolites and outcomes in exposed neonates","volume":"53","author":"Flanagan","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0009","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/14740338.2023.2234813","article-title":"Antenatal thiopurine exposure in women with IBD is associated with intrahepatic cholestasis of pregnancy","volume":"22","author":"Selinger","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"2024080621445598000_CIT0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1471-0528.2011.03245.x","article-title":"Reference standard for serum bile acids in pregnancy","volume":"119","author":"Egan","year":"2012","journal-title":"BJOG"},{"key":"2024080621445598000_CIT0011","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates","volume":"40","author":"Glantz","year":"2004","journal-title":"Hepatology"},{"key":"2024080621445598000_CIT0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinre.2015.12.008","article-title":"The pathophysiology of intrahepatic cholestasis of pregnancy","volume":"40","author":"Dixon","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2024080621445598000_CIT0013","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1038\/s41598-023-35332-z","article-title":"Optimizing maternal and neonatal outcomes through tight control management of inflammatory bowel disease during pregnancy: a pilot feasibility study","volume":"13","author":"Jogendran","year":"2023","journal-title":"Sci Rep"},{"key":"2024080621445598000_CIT0014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/apt.15587","article-title":"Systematic review with meta-analysis: risk of adverse pregnancy-related outcomes in inflammatory bowel disease","volume":"51","author":"Tandon","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.5694\/mja2.51267","article-title":"Evaluation and management of rectal bleeding in pregnancy","volume":"215","author":"Prentice","year":"2021","journal-title":"Med J Aust"},{"key":"2024080621445598000_CIT0016","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/apt.16102","article-title":"Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure","volume":"52","author":"Flanagan","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0017","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/apt.16739","article-title":"Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero","volume":"55","author":"Flanagan","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0018","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ecco-jcc\/jjaa082","article-title":"Monitoring inflammatory bowel disease in pregnancy using gastrointestinal ultrasonography","volume":"14","author":"Flanagan","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2024080621445598000_CIT0019","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1373\/clinchem.2005.050831","article-title":"Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine\/6-mercaptopurine therapy","volume":"51","author":"Dervieux","year":"2005","journal-title":"Clin Chem"},{"key":"2024080621445598000_CIT0020","first-page":"S1","article-title":"Proceedings of the Australasian Association of Clinical Biochemistry and Laboratory Medicine\u2019s 2021 Virtual Scientific Conference. Interference in the measurement of thiopurine metabolites in infants","volume":"42","author":"Mapp","year":"2021","journal-title":"Clin Biochem Rev"},{"key":"2024080621445598000_CIT0021","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"key":"2024080621445598000_CIT0022","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.1965.03090060132017","article-title":"Recurrent intrahepatic cholestasis of pregnancy: observations on pathogenesis","volume":"193","author":"Holzbach","year":"1965","journal-title":"JAMA"},{"key":"2024080621445598000_CIT0023","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/HEP.0000000000000328","article-title":"Familial clustering of intrahepatic cholestasis of pregnancy: a nationwide population-based study in Denmark","volume":"78","author":"Li","year":"2023","journal-title":"Hepatology"},{"key":"2024080621445598000_CIT0024","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.placenta.2011.09.006","article-title":"A placental phenotype for intrahepatic cholestasis of pregnancy","volume":"32","author":"Geenes","year":"2011","journal-title":"Placenta"},{"key":"2024080621445598000_CIT0025","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1080\/14767058.2021.1925645","article-title":"Predictive factors associated with disease recurrence in patients with severe intrahepatic cholestasis of pregnancy: a retrospective study of 118 cases","volume":"35","author":"Wang","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2024080621445598000_CIT0026","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/ecco-jcc\/jjac013","article-title":"Drug-induced liver injury used in the treatment of inflammatory bowel disease","volume":"16","author":"N\u00fa\u00f1ez","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2024080621445598000_CIT0027","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14740338.7.5.607","article-title":"Thiopurine hepatotoxicity in inflammatory bowel disease: the role for adding allopurinol","volume":"7","author":"Leong","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"2024080621445598000_CIT0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"2024080621445598000_CIT0029","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bcp.2013.06.002","article-title":"Mechanism of allopurinol induced TPMT inhibition","volume":"86","author":"Blaker","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"2024080621445598000_CIT0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.gastro.2006.01.046","article-title":"Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis","volume":"130","author":"Osterman","year":"2006","journal-title":"Gastroenterology"},{"key":"2024080621445598000_CIT0031","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MCG.0000000000000568","article-title":"Azathioprine and 6-mercaptopurine-induced liver injury: clinical features and outcomes","volume":"51","author":"Bj\u00f6rnsson","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"2024080621445598000_CIT0032","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cld.398","article-title":"Intrahepatic cholestasis of pregnancy: diagnosis and management","volume":"4","author":"Bacq","year":"2014","journal-title":"Clin Liver Dis [Hoboken]"},{"key":"2024080621445598000_CIT0033","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","article-title":"Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease","volume":"22","author":"Bastida","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0034","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump [Bsep] of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"2024080621445598000_CIT0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.12998\/wjcc.v6.i4.44","article-title":"High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients","volume":"6","author":"Girardin","year":"2018","journal-title":"World J Clin Cases"},{"key":"2024080621445598000_CIT0036","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tjog.2023.07.023","article-title":"Azathioprine and 6-mercaptopurine-induced intrahepatic cholestasis of pregnancy: Case report and review of the literature","volume":"62","author":"Frank Wolf","year":"2023","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2024080621445598000_CIT0037","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2036.2005.02583.x","article-title":"Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine","volume":"22","author":"Sparrow","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0038","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2036.2009.04221.x","article-title":"Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease","volume":"31","author":"Ansari","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"2024080621445598000_CIT0039","first-page":"180","article-title":"The teratogenicity of allopurinol: a comprehensive review of animal and human studies","volume-title":"Reprod Toxicol","author":"Simsek","year":"2018"},{"key":"2024080621445598000_CIT0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/17474124.2013.841541","article-title":"Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the [unborn] child","volume":"7","author":"de Boer","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2024080621445598000_CIT0041","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ecco-jcc\/jjv072","article-title":"Successful pregnancies with thiopurine-allopurinol co-therapy for inflammatory bowel disease","volume":"9","author":"Sheikh","year":"2015","journal-title":"J Crohns Colitis"},{"key":"2024080621445598000_CIT0042","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/imj.15639","article-title":"Low-dose thioguanine guided by therapeutic drug monitoring is a safe and effective alternative in inflammatory bowel disease patients intolerant to conventional thiopurines","volume":"53","author":"Eqbal","year":"2021","journal-title":"Intern Med J"},{"key":"2024080621445598000_CIT0043","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/flgastro-2016-100738","article-title":"A practical guide to thiopurine prescribing and monitoring in IBD","volume":"9","author":"Warner","year":"2018","journal-title":"Frontline Gastroenterol"},{"key":"2024080621445598000_CIT0044","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5217\/ir.2020.00155","article-title":"Use of thiopurines in inflammatory bowel disease: an update","volume":"20","author":"Singh","year":"2022","journal-title":"Intest Res"},{"key":"2024080621445598000_CIT0045","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1080\/00365520510024089","article-title":"6-Thioguanine for Crohn\u2019s disease during pregnancy: thiopurine metabolite measurements in both mother and child","volume":"40","author":"de Boer","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"2024080621445598000_CIT0046","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ecco-jcc\/jjac183","article-title":"Exposure to thioguanine during 117 pregnancies in women with inflammatory bowel disease","volume":"17","author":"Crouwel","year":"2023","journal-title":"J Crohns Colitis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjae023\/56779016\/jjae023.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/18\/7\/1081\/58747581\/jjae023.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/18\/7\/1081\/58747581\/jjae023.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T03:55:10Z","timestamp":1723002910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/18\/7\/1081\/7608699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,2,15]]},"published-print":{"date-parts":[[2024,8,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjae023","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,2,15]]}}}